Quetiapine 100mg Tablets

Manufacturer SUN Active Ingredient Quetiapine Tablets(kwe TYE a peen) Pronunciation kwe TYE a peen
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia.Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children younger than 10 years of age. Talk with the doctor. @ COMMON USES: It is used to treat bipolar disorder. It is used to treat schizophrenia.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Atypical Antipsychotic
🧬
Pharmacologic Class
Serotonin-Dopamine Antagonist (SDA)
🀰
Pregnancy Category
C
βœ…
FDA Approved
Sep 1997
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Quetiapine is a medication used to treat certain mental health conditions like schizophrenia and bipolar disorder. It works by helping to balance certain natural chemicals in the brain. It can help reduce symptoms like hallucinations, delusions, mood swings, and severe depression. It's important to take it regularly as prescribed, even if you feel better.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided to you and follow the instructions closely. You can take this medication with or without food. Continue taking the medication as directed by your doctor or healthcare provider, even if you start feeling well.

Important Warnings and Precautions

Avoid consuming alcohol while taking this medication.
Before using marijuana, other forms of cannabis, or prescription or over-the-counter (OTC) medications that may slow your reactions, consult with your doctor.
Do not stop taking this medication abruptly without consulting your doctor, as this may increase your risk of withdrawal symptoms. If you need to stop taking the medication, your doctor will advise you on how to gradually discontinue it.

Staying Hydrated and Managing Your Condition

Drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your fluid intake.
Be cautious in hot weather or when engaging in physical activity, and drink plenty of fluids to prevent dehydration.
Follow your doctor's instructions for getting your blood work checked and having regular eye exams.

Interactions with Lab Tests and Other Medications

This medication may affect certain lab tests, so inform all your healthcare providers and lab personnel that you are taking this medication.
Monitor your blood sugar levels as directed by your doctor.

Storing and Disposing of Your Medication

Store the medication at room temperature, protected from light, and in a dry place. Do not store it in a bathroom.
Keep all medications in a safe place, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. Consult your pharmacist for guidance on the best way to dispose of medications, and check if there are any drug take-back programs in your area.

What to Do If You Miss a Dose

Take a missed dose as soon as you remember.
If it's close to the time for your next dose, skip the missed dose and resume your regular schedule.
Do not take two doses at the same time or take extra doses.
* If you're unsure what to do if you miss a dose, consult your doctor.
πŸ’‘

Lifestyle & Tips

  • Avoid alcohol and other CNS depressants, as they can increase drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how this medication affects you, especially at the start of treatment.
  • Stand up slowly from a sitting or lying position to avoid dizziness or fainting.
  • Monitor your weight and diet, as this medication can cause weight gain and changes in blood sugar and cholesterol.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms or worsening of your condition.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Varies by indication and formulation (immediate-release vs. extended-release). For immediate-release (IR) tablets, typical starting doses are 25-50 mg twice daily, titrated upwards. For schizophrenia, target dose is 150-750 mg/day in 2-3 divided doses. For bipolar mania, 100-800 mg/day in 2 divided doses. For bipolar depression, 300 mg at bedtime.
Dose Range: 25 - 800 mg

Condition-Specific Dosing:

schizophrenia: Initial: 25 mg BID, titrate to 300-400 mg/day by Day 4. Usual effective range: 150-750 mg/day.
bipolar_mania: Initial: 50 mg BID on Day 1, 100 mg BID on Day 2, 150 mg BID on Day 3, 200 mg BID on Day 4. Usual effective range: 400-800 mg/day.
bipolar_depression: Initial: 50 mg at bedtime on Day 1, 100 mg on Day 2, 200 mg on Day 3, 300 mg on Day 4. Target dose: 300 mg at bedtime.
maintenance_bipolar: 400-800 mg/day in 2 divided doses.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for children under 10 years.
Adolescent: For schizophrenia (13-17 years): Initial 25 mg BID, titrate to 400-800 mg/day. For bipolar mania (10-17 years): Initial 25 mg BID, titrate to 400-600 mg/day.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment generally required.
Moderate: No dosage adjustment generally required.
Severe: No dosage adjustment generally required, but use with caution.
Dialysis: Not significantly removed by dialysis. No specific adjustment, but monitor for adverse effects.

Hepatic Impairment:

Mild: Consider starting with 25 mg/day (IR) or 50 mg/day (XR) and titrate slowly.
Moderate: Start with 25 mg/day (IR) or 50 mg/day (XR) and titrate slowly, monitoring for adverse effects.
Severe: Start with 25 mg/day (IR) or 50 mg/day (XR) and titrate slowly, monitoring for adverse effects. Use with extreme caution.

Pharmacology

πŸ”¬

Mechanism of Action

Quetiapine is an atypical antipsychotic. Its antipsychotic activity is thought to be mediated through a combination of antagonism at dopamine D2 and serotonin 5-HT2A receptors. It also has high affinity for histamine H1 receptors and adrenergic alpha1 and alpha2 receptors, which may contribute to some of its side effects (e.g., sedation, orthostatic hypotension). It has moderate affinity for serotonin 5-HT1A receptors and muscarinic M1 receptors.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Not explicitly stated as a percentage, but rapidly and well absorbed.
Tmax: 1.5 hours (IR), 6 hours (XR)
FoodEffect: Food increases Cmax and AUC by 15% and 18% respectively for IR tablets. For XR tablets, food increases Cmax by 45% and AUC by 20%.

Distribution:

Vd: 10 Β± 4 L/kg
ProteinBinding: Approximately 83%
CnssPenetration: Yes

Elimination:

HalfLife: Approximately 6-7 hours (quetiapine), 10-12 hours (norquetiapine)
Clearance: Not available (variable)
ExcretionRoute: Urine (73%), Feces (20%)
Unchanged: Less than 1% (quetiapine), 5% (norquetiapine)
⏱️

Pharmacodynamics

OnsetOfAction: Sedation: within 30 minutes. Antipsychotic effects: days to weeks.
PeakEffect: Antipsychotic effects: several weeks.
DurationOfAction: Approximately 12 hours (IR), 24 hours (XR) for therapeutic effects, but sedation can be shorter.

Safety & Warnings

⚠️

BLACK BOX WARNING

Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Antipsychotic drugs, including quetiapine, increase the risk of death in elderly patients with dementia-related psychosis. Quetiapine is not approved for the treatment of dementia-related psychosis. Suicidal Thoughts and Behaviors: Antidepressants increased the risk compared to placebo of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Quetiapine is not approved for use in pediatric patients with depression. Closely monitor all patients for clinical worsening, suicidality, or unusual changes in behavior.
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low thyroid levels, including:
+ Constipation
+ Sensitivity to cold
+ Memory problems
+ Mood changes
+ Burning, numbness, or tingling sensations that are not normal
Severe dizziness or fainting
Chest pain or pressure, rapid heartbeat, or irregular heartbeat
Difficulty controlling body movements, twitching, balance problems, trouble swallowing or speaking
Shakiness, difficulty moving around, or stiffness
Drooling
Seizures
Changes in vision
Severe constipation or stomach pain, which may be signs of a serious bowel problem
Difficulty urinating
Flu-like symptoms
Enlarged breasts, nipple discharge, erectile dysfunction, or menstrual changes
Tardive dyskinesia, a severe muscle problem that may cause involuntary movements, particularly in people with diabetes and older adults, especially older females. The risk increases with longer use or higher doses, but can also occur after short-term use with low doses. If you experience trouble controlling body movements or problems with your tongue, face, mouth, or jaw, such as tongue sticking out, puffing cheeks, mouth puckering, or chewing, contact your doctor immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical attention:

Dizziness, drowsiness, fatigue, or weakness
Headache
Nervousness or excitability
Sleep disturbances
Constipation
Dry mouth
Increased appetite
Weight gain
Upset stomach or vomiting
Stomach pain
Back pain
Stuffy nose

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting when standing up
  • Excessive drowsiness or sedation
  • Unexplained fever, muscle stiffness, confusion, or sweating (signs of Neuroleptic Malignant Syndrome - NMS)
  • Uncontrolled movements of the face, tongue, or other body parts (signs of Tardive Dyskinesia - TD)
  • Increased thirst, frequent urination, or increased hunger (signs of high blood sugar)
  • Sore throat, fever, chills, or other signs of infection (potential blood problems)
  • Yellowing of the skin or eyes, dark urine, or persistent nausea/vomiting (potential liver problems)
  • Thoughts of harming yourself or others, or worsening depression/anxiety
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have low levels of potassium or magnesium in your blood.
If you have a history of abnormal heart rhythms, including a prolonged QT interval on an electrocardiogram (ECG).
If you are taking any medications that can cause abnormal heart rhythms, such as those that prolong the QT interval. There are many medications that can have this effect, so it is crucial to ask your doctor or pharmacist if you are unsure.

Please note that this is not an exhaustive list of all potential interactions between this medication and other substances or health conditions. To ensure your safety, it is vital to:

Inform your doctor and pharmacist about all medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins.
Share information about any health problems you have.
Verify that it is safe to take this medication with all your other medications and health conditions.
Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions for Patients Taking This Medication

If you are taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, about your treatment.

Precautions to Avoid Adverse Effects

To minimize the risk of accidents, avoid driving and engaging in activities that require alertness until you understand how this medication affects you. When changing positions, get up slowly from sitting or lying down to reduce the risk of dizziness or fainting. Be cautious when climbing stairs.

Potential Side Effects and Risks

Rarely, cataracts may develop in patients taking this medication. Additionally, there is a risk of developing high blood sugar, diabetes, high cholesterol, and weight gain, which may increase the likelihood of heart and brain blood vessel disease. Monitor your condition and report any signs of high blood sugar, such as confusion, drowsiness, unusual thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath, to your doctor.

Low white blood cell counts have been reported in patients taking similar medications, which may increase the risk of infection. In rare cases, these infections can be life-threatening. Inform your doctor if you have a history of low white blood cell count and seek medical attention immediately if you experience symptoms of infection, such as fever, chills, or sore throat.

Life-Threatening Conditions

A rare but potentially life-threatening condition called neuroleptic malignant syndrome (NMS) may occur. Seek medical attention immediately if you experience any of the following symptoms: fever, muscle cramps or stiffness, dizziness, severe headache, confusion, changes in thinking, rapid heartbeat, irregular heartbeat, or excessive sweating.

Increased Risk of Falls and Injuries

This medication may cause dizziness, drowsiness, and impaired balance, which may increase the risk of falls and subsequent injuries, such as fractures. Exercise caution to minimize this risk.

Gastrointestinal Risks

Constipation is a common side effect of this medication. In rare cases, bowel obstruction may occur, which can be life-threatening when combined with other medications that slow gastrointestinal movement. If you have concerns, discuss them with your doctor.

Special Considerations for Older Adults

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. Older adults with dementia who take similar medications have a higher risk of stroke, which can be life-threatening. This medication is not approved for treating dementia-related mental health issues.

Reproductive and Pregnancy Considerations

This medication may affect fertility, but this effect is reversible when the medication is discontinued. If you have concerns, discuss them with your doctor. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to weigh the benefits and risks to you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.

Pediatric Considerations

If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children. High blood pressure has been reported in children and teenagers taking this medication. Regularly monitor your child's blood pressure as advised by their doctor.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Severe drowsiness
  • Sedation
  • Low blood pressure (hypotension)
  • Fast heartbeat (tachycardia)
  • Coma
  • QT prolongation
  • Arrhythmias

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive, including maintaining an open airway, ensuring adequate oxygenation and ventilation, and monitoring cardiovascular function.

Drug Interactions

πŸ”΄

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin, protease inhibitors): Significantly increase quetiapine levels, leading to increased adverse effects. Co-administration is generally not recommended.
  • Strong CYP3A4 inducers (e.g., phenytoin, carbamazepine, rifampin, barbiturates): Significantly decrease quetiapine levels, leading to loss of efficacy. Dosage adjustment of quetiapine or alternative therapy may be needed.
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, moxifloxacin, thioridazine): Increased risk of cardiac arrhythmias. Use with caution.
🟑

Moderate Interactions

  • CNS depressants (e.g., alcohol, benzodiazepines, opioids): Additive sedative effects.
  • Antihypertensives: Additive hypotensive effects due to alpha1-adrenergic blockade.
  • Anticholinergic drugs: Additive anticholinergic effects (e.g., constipation, dry mouth, urinary retention).
  • Dopamine agonists (e.g., levodopa): Quetiapine may antagonize the effects of dopamine agonists.
🟒

Minor Interactions

  • Grapefruit juice: May inhibit CYP3A4, leading to slight increase in quetiapine levels (avoid large amounts).

Monitoring

πŸ”¬

Baseline Monitoring

Weight/BMI

Rationale: Risk of weight gain and metabolic changes.

Timing: Before initiation

Fasting Plasma Glucose (FPG) or HbA1c

Rationale: Risk of hyperglycemia and diabetes.

Timing: Before initiation

Lipid Panel (Fasting)

Rationale: Risk of dyslipidemia.

Timing: Before initiation

Blood Pressure (Orthostatic)

Rationale: Risk of orthostatic hypotension.

Timing: Before initiation

Complete Blood Count (CBC) with differential

Rationale: Risk of neutropenia/leukopenia.

Timing: Before initiation

Liver Function Tests (LFTs)

Rationale: Metabolized by liver; risk of hepatic impairment.

Timing: Before initiation

ECG

Rationale: Consider if patient has cardiac risk factors or history of QT prolongation.

Timing: Before initiation (if indicated)

πŸ“Š

Routine Monitoring

Weight/BMI

Frequency: Monthly for first few months, then quarterly

Target: Maintain healthy range

Action Threshold: Significant weight gain (e.g., >5% baseline)

Fasting Plasma Glucose (FPG) or HbA1c

Frequency: At 3 months, then annually (or more frequently if risk factors/changes)

Target: FPG <100 mg/dL, HbA1c <5.7%

Action Threshold: FPG β‰₯126 mg/dL or HbA1c β‰₯6.5%

Lipid Panel (Fasting)

Frequency: At 3 months, then annually (or more frequently if risk factors/changes)

Target: LDL <100 mg/dL, Triglycerides <150 mg/dL

Action Threshold: Significant elevations

Blood Pressure (Orthostatic)

Frequency: Regularly during titration, then periodically

Target: Stable BP, no significant orthostatic drop

Action Threshold: Symptomatic orthostasis or significant drop (>20 mmHg systolic, >10 mmHg diastolic)

Complete Blood Count (CBC) with differential

Frequency: Periodically, or if signs of infection

Target: WNL

Action Threshold: Neutropenia (ANC <1.5 x 10^9/L)

Liver Function Tests (LFTs)

Frequency: Periodically, or if signs of hepatic dysfunction

Target: WNL

Action Threshold: Significant elevation (e.g., >3x ULN)

Extrapyramidal Symptoms (EPS) / Tardive Dyskinesia (TD) assessment (e.g., AIMS)

Frequency: Periodically (e.g., every 6-12 months)

Target: Absence of symptoms

Action Threshold: Emergence or worsening of symptoms

Mental Status / Clinical Response

Frequency: Regularly throughout treatment

Target: Symptom control, functional improvement

Action Threshold: Worsening of symptoms, emergence of new symptoms, suicidal ideation

πŸ‘οΈ

Symptom Monitoring

  • Dizziness or lightheadedness (especially when standing)
  • Excessive sedation or somnolence
  • Unusual weight gain
  • Increased thirst or urination
  • Muscle stiffness or tremors
  • Restlessness or agitation
  • Uncontrolled movements (especially of face, tongue, or limbs)
  • Fever, severe muscle stiffness, confusion, sweating, or rapid heart rate (signs of NMS)
  • Sore throat, fever, or other signs of infection (potential neutropenia)
  • Yellowing of skin or eyes, dark urine (potential liver issues)
  • Changes in mood or behavior, suicidal thoughts (especially in young adults)

Special Patient Groups

🀰

Pregnancy

Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but no clear evidence of increased major malformation risk.
Second Trimester: Limited data.
Third Trimester: Risk of extrapyramidal symptoms (e.g., tremor, hypertonia, hypotonia, somnolence, agitation, respiratory distress, feeding disorder) and/or withdrawal symptoms in neonates. Monitor neonates for these symptoms.
🀱

Lactation

Quetiapine and its active metabolite are excreted into human breast milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for quetiapine, and any potential adverse effects on the breastfed infant from quetiapine or from the underlying maternal condition. Monitor infants for sedation, poor feeding, and weight gain.

Infant Risk: L3 (Moderately Safe - Limited controlled studies show no increase in adverse effects, or only minor non-serious adverse effects. Risk of adverse effects is possible, but unlikely.)
πŸ‘Ά

Pediatric Use

Not approved for use in children under 10 years. For adolescents (10-17 years) with schizophrenia or bipolar mania, dosing is adjusted. Black Box Warning regarding increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults.

πŸ‘΄

Geriatric Use

Increased risk of orthostatic hypotension, sedation, and falls. Increased risk of cerebrovascular adverse events (e.g., stroke, transient ischemic attack) and increased mortality in elderly patients with dementia-related psychosis (Black Box Warning). Start with lower doses (e.g., 25 mg/day) and titrate more slowly. Monitor closely for adverse effects.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Quetiapine is highly sedating, especially at lower doses, and is often taken at bedtime. This can be beneficial for patients with insomnia.
  • Titration is crucial to minimize side effects like orthostatic hypotension and sedation. Do not start at the full target dose.
  • Metabolic monitoring (weight, glucose, lipids) is essential due to the significant risk of metabolic side effects.
  • Immediate-release (IR) and extended-release (XR) formulations are not interchangeable on a milligram-for-milligram basis due to different pharmacokinetic profiles and dosing schedules.
  • Patients should be advised to avoid sudden discontinuation to prevent withdrawal symptoms (e.g., insomnia, nausea, vomiting, headache, diarrhea, dizziness, irritability).
πŸ”„

Alternative Therapies

  • Other atypical antipsychotics (e.g., Olanzapine, Risperidone, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine)
  • Mood stabilizers (e.g., Lithium, Valproate, Lamotrigine) for bipolar disorder
  • Antidepressants (e.g., SSRIs, SNRIs) for bipolar depression (often in combination with a mood stabilizer or antipsychotic)
  • Cognitive Behavioral Therapy (CBT)
  • Electroconvulsive Therapy (ECT) for severe or treatment-resistant cases
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $10-$100+ per 30 tablets (100mg IR)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic), Tier 3 or higher (brand)
πŸ“š

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure your safety and the effectiveness of your treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a valuable resource that provides important information about your treatment. Please read this guide carefully when you first receive your medication and review it again each time your prescription is refilled. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, it is crucial to seek immediate medical attention. Call your local poison control center or visit the emergency room right away. When seeking help, be prepared to provide detailed information about the overdose, including the name of the medication taken, the amount consumed, and the time it occurred. This information will help healthcare professionals provide you with the most effective treatment and care.